By Thomas M. Burton WASHINGTON U.S. government scientists are pushing back against calls for one-dose regimens for two Covid-19 vaccines designed to be administered with two shots, saying there isn t enough evidence that a single dose provides long-term protection. It is essential that these vaccines be used as authorized by FDA in order to prevent Covid-19 and related hospitalizations and death, Peter Marks, director of the Food and Drug Administration s center that oversees vaccines, told The Wall Street Journal. The FDA late last year approved a two-dose regimen for vaccines from Moderna Inc. and from a partnership of Pfizer Inc. and BioNTech SE. More recently it approved use of a one-dose regimen for a vaccine from Johnson & Johnson.
Swing brings liberty for Kaitaia s disabled community
7 Mar, 2021 04:00 PM
2 minutes to read
Northern Advocate
A very special swing, specifically designed for children and adults in wheelchairs, has been installed at Kaitaia s Jaycee Park.
It is part of the Jaycee/Centennial Park development project, which has already seen footpaths widened to improve accessibility.
The $18,000 Australian-made Liberty swing, one of three that will be installed around the Far North, one in the Bay of Islands-Whangaroa ward and the third in the Kaikohe-Hokianga ward, allows wheelchair users to gain maximum height, as opposed to simply rocking back and forth. It includes an access ramp, a moulded plastic capsule with an internal steel frame, and a seatbelt to secure the wheelchair.
By Thomas M. Burton WASHINGTON U.S. government scientists are pushing back against calls for one-dose regimens for two Covid-19 vaccines designed to be administered with two shots, saying there isn t enough evidence that a single dose provides long-term protection. It is essential that these vaccines be used as authorized by FDA in order to prevent Covid-19 and related hospitalizations and death, Peter Marks, director of the Food and Drug Administration s center that oversees vaccines, told The Wall Street Journal. The FDA late last year approved a two-dose regimen for vaccines from Moderna Inc. and from a partnership of Pfizer Inc. and BioNTech SE. More recently it approved use of a one-dose regimen for a vaccine from Johnson & Johnson.